Michela Perrone

A TrendSanità ebook takes stock of the reproductive issue in Poland: Maria Boratyńska, Professor of Health Law and secretary of the Bioethics Committee of the Polish Academy of Sciences, summarizes -on the eve of the elections – the main issues on abortion rights and in vitro fertilization in her country

Assistants often mistaken for doctors: they have existed in the UK for decades to at least partially counteract the shortage of medical staff. Today, however, despite plans to increase their numbers, they are becoming a problem

The European Medicines Agency recently launched the first version of a platform to automate and standardise data collection on drug shortages. Monica Dias, Head of Supply and Availability of medicines and medical devices at EMA, discusses it with TrendSanità

There is a shortage of GPs throughout Europe and it is not just a question of remuneration. According to Tiago Villanueva, President of UEMO, ways must be found to keep the younger generation within the general practice pathway

Alessandro Vespignani, among the world’s leading experts in computational epidemiology, tells TrendSanità what the future of infectious disease prediction looks like. It starts from widespread organization at the supranational level to a network of sentinels at airports to measure the movement of viruses

Almost 40 years after the Ottawa Charter, the International Network of Hospitals for Health Promotion and Health Services (HPH) aims at people’s well-being through cultural welfare

Health-related issues have not been the focus of the (poor) European election campaign: these are national competencies and there is a struggle to find joint solutions.
On Across Europe the main challenges for the next 5 years

We cannot rest on our laurels: this is how the Director General for Health and Food Safety at the EU Commission calls on Member States to play their part

Interviewed by TrendSanità, the Belgian Minister of Health and Social Affairs spoke about the major challenges that the European Union has in front of it regarding healthcare: in addition to the use of data (for which an agreement was reached at mid-March), drug and personnel shortages, pharmaceutical reform and artificial intelligence